 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0015403	thiamine uptake transmembrane transporter activity	1	1.015605e-4	3.745551e-1	3.745551e-1	9.846350e+3	1.015605e-4	1	1.015605e-4	1.000000e+0	1	2.217111e-4	8.176705e-1	8.176705e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	SLC19A3
GO Molecular Function	GO:0015563	uptake transmembrane transporter activity	2	1.138134e-4	4.197438e-1	2.098719e-1	8.786308e+3	1.138134e-4	1	1.138134e-4	1.000000e+0	2	3.325574e-4	1.000000e+0	6.132358e-1	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	SLC19A3
GO Molecular Function	GO:0090482	vitamin transmembrane transporter activity	3	2.186084e-4	8.062278e-1	2.687426e-1	4.574389e+3	2.186084e-4	1	2.186084e-4	1.000000e+0	3	5.542315e-4	1.000000e+0	6.813353e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	SLC19A3
GO Molecular Function	GO:1901474	azole transmembrane transporter activity	4	4.422672e-4	1.000000e+0	4.077704e-1	2.261076e+3	4.422672e-4	1	4.422672e-4	1.000000e+0	3	5.542315e-4	1.000000e+0	6.813353e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	SLC19A3
GO Molecular Function	GO:0015238	drug transmembrane transporter activity	5	1.036883e-3	1.000000e+0	7.648049e-1	9.644294e+2	1.036883e-3	1	1.036883e-3	1.000000e+0	5	1.662234e-3	1.000000e+0	1.000000e+0	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	SLC19A3
GO Molecular Function	GO:0051183	vitamin transporter activity	6	1.084612e-3	1.000000e+0	6.666748e-1	9.219889e+2	1.084612e-3	1	1.084612e-3	1.000000e+0	6	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	SLC19A3
GO Molecular Function	GO:0090484	drug transporter activity	7	1.203657e-3	1.000000e+0	6.341553e-1	8.308012e+2	1.203657e-3	1	1.203657e-3	1.000000e+0	6	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	SLC19A3
GO Molecular Function	GO:1901682	sulfur compound transmembrane transporter activity	8	2.334460e-3	1.000000e+0	1.000000e+0	4.283645e+2	2.334460e-3	1	2.334460e-3	1.000000e+0	8	2.769621e-3	1.000000e+0	1.000000e+0	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	SLC19A3
GO Molecular Function	GO:0022891	substrate-specific transmembrane transporter activity	9	8.482288e-2	1.000000e+0	1.000000e+0	1.178927e+1	8.482288e-2	1	8.482288e-2	1.000000e+0	9	8.926381e-2	1.000000e+0	1.000000e+0	1.094721e+1	9.134749e-2	1	824	5.000000e-1	1.213592e-3	unnamed	SLC19A3
GO Molecular Function	GO:0022857	transmembrane transporter activity	10	9.170810e-2	1.000000e+0	1.000000e+0	1.090416e+1	9.170810e-2	1	9.170810e-2	1.000000e+0	10	9.802388e-2	1.000000e+0	1.000000e+0	9.945424e+0	1.005488e-1	1	907	5.000000e-1	1.102536e-3	unnamed	SLC19A3
GO Molecular Function	GO:0022892	substrate-specific transporter activity	11	9.245642e-2	1.000000e+0	1.000000e+0	1.081591e+1	9.245642e-2	1	9.245642e-2	1.000000e+0	11	1.030706e-1	1.000000e+0	1.000000e+0	9.445550e+0	1.058700e-1	1	955	5.000000e-1	1.047120e-3	unnamed	SLC19A3
GO Molecular Function	GO:0005215	transporter activity	12	1.089898e-1	1.000000e+0	1.000000e+0	9.175171e+0	1.089898e-1	1	1.089898e-1	1.000000e+0	12	1.269529e-1	1.000000e+0	1.000000e+0	7.618666e+0	1.312566e-1	1	1184	5.000000e-1	8.445946e-4	unnamed	SLC19A3
GO Biological Process	GO:0015888	thiamine transport	1	1.015605e-4	1.000000e+0	1.000000e+0	9.846350e+3	1.015605e-4	1	1.015605e-4	1.000000e+0	1	2.217111e-4	1.000000e+0	1.000000e+0	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	SLC19A3
GO Biological Process	GO:0042723	thiamine-containing compound metabolic process	2	6.327246e-4	1.000000e+0	1.000000e+0	1.580466e+3	6.327246e-4	1	6.327246e-4	1.000000e+0	2	5.542315e-4	1.000000e+0	1.000000e+0	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	SLC19A3
GO Biological Process	GO:0051180	vitamin transport	3	1.367860e-3	1.000000e+0	1.000000e+0	7.310690e+2	1.367860e-3	1	1.367860e-3	1.000000e+0	4	2.658910e-3	1.000000e+0	1.000000e+0	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	SLC19A3
GO Biological Process	GO:0072348	sulfur compound transport	4	1.880044e-3	1.000000e+0	1.000000e+0	5.319024e+2	1.880044e-3	1	1.880044e-3	1.000000e+0	5	2.991025e-3	1.000000e+0	1.000000e+0	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	SLC19A3
GO Biological Process	GO:0045117	azole transport	5	1.976932e-3	1.000000e+0	1.000000e+0	5.058343e+2	1.976932e-3	1	1.976932e-3	1.000000e+0	3	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	SLC19A3
GO Biological Process	GO:0015893	drug transport	6	3.117582e-3	1.000000e+0	1.000000e+0	3.207614e+2	3.117582e-3	1	3.117582e-3	1.000000e+0	6	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	SLC19A3
GO Biological Process	GO:0072527	pyrimidine-containing compound metabolic process	7	6.706757e-3	1.000000e+0	1.000000e+0	1.491033e+2	6.706757e-3	1	6.706757e-3	1.000000e+0	7	8.297342e-3	1.000000e+0	1.000000e+0	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	SLC19A3
GO Biological Process	GO:0006767	water-soluble vitamin metabolic process	8	8.493979e-3	1.000000e+0	1.000000e+0	1.177305e+2	8.493979e-3	1	8.493979e-3	1.000000e+0	8	9.732033e-3	1.000000e+0	1.000000e+0	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	SLC19A3
GO Biological Process	GO:0006766	vitamin metabolic process	9	1.089445e-2	1.000000e+0	1.000000e+0	9.178985e+1	1.089445e-2	1	1.089445e-2	1.000000e+0	9	1.281861e-2	1.000000e+0	1.000000e+0	7.776293e+1	1.285960e-2	1	116	5.000000e-1	8.620690e-3	unnamed	SLC19A3
GO Biological Process	GO:0006790	sulfur compound metabolic process	10	2.820341e-2	1.000000e+0	1.000000e+0	3.545671e+1	2.820341e-2	1	2.820341e-2	1.000000e+0	10	2.675795e-2	1.000000e+0	1.000000e+0	3.712140e+1	2.693864e-2	1	243	5.000000e-1	4.115226e-3	unnamed	SLC19A3
GO Biological Process	GO:0071705	nitrogen compound transport	11	3.671157e-2	1.000000e+0	1.000000e+0	2.723937e+1	3.671157e-2	1	3.671157e-2	1.000000e+0	14	4.666947e-2	1.000000e+0	1.000000e+0	2.117488e+1	4.722576e-2	1	426	5.000000e-1	2.347418e-3	unnamed	SLC19A3
GO Biological Process	GO:0042493	response to drug	12	4.125969e-2	1.000000e+0	1.000000e+0	2.423673e+1	4.125969e-2	1	4.125969e-2	1.000000e+0	13	3.929468e-2	1.000000e+0	1.000000e+0	2.519693e+1	3.968738e-2	1	358	5.000000e-1	2.793296e-3	unnamed	SLC19A3
GO Biological Process	GO:1901564	organonitrogen compound metabolic process	13	1.379740e-1	1.000000e+0	1.000000e+0	7.247740e+0	1.379740e-1	1	1.379740e-1	1.000000e+0	16	1.637442e-1	1.000000e+0	1.000000e+0	5.846079e+0	1.710548e-1	1	1543	5.000000e-1	6.480881e-4	unnamed	SLC19A3
GO Biological Process	GO:0071702	organic substance transport	14	1.396970e-1	1.000000e+0	1.000000e+0	7.158351e+0	1.396970e-1	1	1.396970e-1	1.000000e+0	17	1.786811e-1	1.000000e+0	1.000000e+0	5.334418e+0	1.874619e-1	1	1691	5.000000e-1	5.913661e-4	unnamed	SLC19A3
GO Biological Process	GO:0044281	small molecule metabolic process	15	2.001784e-1	1.000000e+0	1.000000e+0	4.995545e+0	2.001784e-1	1	2.001784e-1	1.000000e+0	18	2.509628e-1	1.000000e+0	1.000000e+0	3.716728e+0	2.690538e-1	1	2427	5.000000e-1	4.120313e-4	unnamed	SLC19A3
GO Biological Process	GO:0044765	single-organism transport	16	2.288177e-1	1.000000e+0	1.000000e+0	4.370291e+0	2.288177e-1	1	2.288177e-1	1.000000e+0	19	2.680389e-1	1.000000e+0	1.000000e+0	3.461435e+0	2.888975e-1	1	2606	5.000000e-1	3.837299e-4	unnamed	SLC19A3
GO Biological Process	GO:0044710	single-organism metabolic process	17	2.517961e-1	1.000000e+0	1.000000e+0	3.971468e+0	2.517961e-1	1	2.517961e-1	1.000000e+0	20	3.105584e-1	1.000000e+0	1.000000e+0	2.946913e+0	3.393382e-1	1	3061	5.000000e-1	3.266906e-4	unnamed	SLC19A3
GO Biological Process	GO:0006810	transport	18	2.770578e-1	1.000000e+0	1.000000e+0	3.609355e+0	2.770578e-1	1	2.770578e-1	1.000000e+0	11	3.272428e-2	1.000000e+0	1.000000e+0	5.527267e+0	3.618425e-1	2	3264	1.000000e+0	6.127451e-4	unnamed	C2orf83,SLC19A3
GO Biological Process	GO:0051234	establishment of localization	19	2.827781e-1	1.000000e+0	1.000000e+0	3.536342e+0	2.827781e-1	1	2.827781e-1	1.000000e+0	12	3.373470e-2	1.000000e+0	1.000000e+0	5.443874e+0	3.673854e-1	2	3314	1.000000e+0	6.035003e-4	unnamed	C2orf83,SLC19A3
GO Biological Process	GO:0042221	response to chemical stimulus	20	2.954524e-1	1.000000e+0	1.000000e+0	3.384640e+0	2.954524e-1	1	2.954524e-1	1.000000e+0	21	3.326549e-1	1.000000e+0	1.000000e+0	2.731002e+0	3.661660e-1	1	3303	5.000000e-1	3.027551e-4	unnamed	SLC19A3
GO Biological Process	GO:0051179	localization	21	3.597525e-1	1.000000e+0	1.000000e+0	2.779689e+0	3.597525e-1	1	3.597525e-1	1.000000e+0	15	4.993858e-2	1.000000e+0	1.000000e+0	4.474454e+0	4.469819e-1	2	4032	1.000000e+0	4.960317e-4	unnamed	C2orf83,SLC19A3
GO Biological Process	GO:0046483	heterocycle metabolic process	22	3.657512e-1	1.000000e+0	1.000000e+0	2.734099e+0	3.657512e-1	1	3.657512e-1	1.000000e+0	22	4.495636e-1	1.000000e+0	1.000000e+0	1.937393e+0	5.161576e-1	1	4656	5.000000e-1	2.147766e-4	unnamed	SLC19A3
GO Biological Process	GO:0006725	cellular aromatic compound metabolic process	23	3.683046e-1	1.000000e+0	1.000000e+0	2.715144e+0	3.683046e-1	1	3.683046e-1	1.000000e+0	23	4.506323e-1	1.000000e+0	1.000000e+0	1.931998e+0	5.175988e-1	1	4669	5.000000e-1	2.141786e-4	unnamed	SLC19A3
GO Biological Process	GO:0034641	cellular nitrogen compound metabolic process	24	3.768107e-1	1.000000e+0	1.000000e+0	2.653853e+0	3.768107e-1	1	3.768107e-1	1.000000e+0	24	4.663767e-1	1.000000e+0	1.000000e+0	1.855306e+0	5.389945e-1	1	4862	5.000000e-1	2.056767e-4	unnamed	SLC19A3
GO Biological Process	GO:1901360	organic cyclic compound metabolic process	25	3.827617e-1	1.000000e+0	1.000000e+0	2.612592e+0	3.827617e-1	1	3.827617e-1	1.000000e+0	25	4.683993e-1	1.000000e+0	1.000000e+0	1.845815e+0	5.417660e-1	1	4887	5.000000e-1	2.046245e-4	unnamed	SLC19A3
GO Biological Process	GO:0006807	nitrogen compound metabolic process	26	4.138051e-1	1.000000e+0	1.000000e+0	2.416597e+0	4.138051e-1	1	4.138051e-1	1.000000e+0	26	4.994558e-1	1.000000e+0	1.000000e+0	1.709399e+0	5.850008e-1	1	5277	5.000000e-1	1.895016e-4	unnamed	SLC19A3
GO Biological Process	GO:0050896	response to stimulus	27	5.533212e-1	1.000000e+0	1.000000e+0	1.807268e+0	5.533212e-1	1	5.533212e-1	1.000000e+0	27	6.177696e-1	1.000000e+0	1.000000e+0	1.309787e+0	7.634832e-1	1	6887	5.000000e-1	1.452011e-4	unnamed	SLC19A3
GO Biological Process	GO:0044237	cellular metabolic process	28	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	28	7.045181e-1	1.000000e+0	1.000000e+0	1.095519e+0	9.128097e-1	1	8234	5.000000e-1	1.214477e-4	unnamed	SLC19A3
GO Biological Process	GO:0071704	organic substance metabolic process	29	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	29	7.239536e-1	1.000000e+0	1.000000e+0	1.053551e+0	9.491713e-1	1	8562	5.000000e-1	1.167951e-4	unnamed	SLC19A3
GO Biological Process	GO:0008152	metabolic process	30	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	30	7.596471e-1	1.000000e+0	1.000000e+0	9.809156e-1	1.019456e+0	1	9196	5.000000e-1	1.087429e-4	unnamed	SLC19A3
GO Biological Process	GO:0044699	single-organism process	31	7.935590e-1	1.000000e+0	1.000000e+0	1.260146e+0	7.935590e-1	1	7.935590e-1	1.000000e+0	31	8.529291e-1	1.000000e+0	1.000000e+0	8.110502e-1	1.232969e+0	1	11122	5.000000e-1	8.991189e-5	unnamed	SLC19A3
GO Biological Process	GO:0009987	cellular process	32	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	32	9.369062e-1	1.000000e+0	1.000000e+0	6.677400e-1	1.497589e+0	1	13509	5.000000e-1	7.402472e-5	unnamed	SLC19A3
GO Cellular Component	GO:0005886	plasma membrane	1	4.126577e-1	1.000000e+0	1.000000e+0	2.423316e+0	4.126577e-1	1	4.126577e-1	1.000000e+0	2	4.264607e-1	1.000000e+0	1.000000e+0	2.060416e+0	4.853390e-1	1	4378	5.000000e-1	2.284148e-4	unnamed	SLC19A3
GO Cellular Component	GO:0071944	cell periphery	2	4.194602e-1	1.000000e+0	1.000000e+0	2.384017e+0	4.194602e-1	1	4.194602e-1	1.000000e+0	3	4.347424e-1	1.000000e+0	1.000000e+0	2.014854e+0	4.963140e-1	1	4477	5.000000e-1	2.233639e-4	unnamed	SLC19A3
GO Cellular Component	GO:0016021	integral to membrane	3	4.578656e-1	1.000000e+0	1.000000e+0	2.184047e+0	4.578656e-1	1	4.578656e-1	1.000000e+0	4	4.982001e-1	1.000000e+0	1.000000e+0	1.714598e+0	5.832271e-1	1	5261	5.000000e-1	1.900779e-4	unnamed	SLC19A3
GO Cellular Component	GO:0031224	intrinsic to membrane	4	4.694206e-1	1.000000e+0	1.000000e+0	2.130286e+0	4.694206e-1	1	4.694206e-1	1.000000e+0	5	5.070350e-1	1.000000e+0	1.000000e+0	1.678545e+0	5.957541e-1	1	5374	5.000000e-1	1.860811e-4	unnamed	SLC19A3
GO Cellular Component	GO:0044425	membrane part	5	5.293034e-1	1.000000e+0	1.000000e+0	1.889276e+0	5.293034e-1	1	5.293034e-1	1.000000e+0	6	5.687230e-1	1.000000e+0	1.000000e+0	1.456564e+0	6.865473e-1	1	6193	5.000000e-1	1.614726e-4	unnamed	SLC19A3
GO Cellular Component	GO:0016020	membrane	6	6.308744e-1	1.000000e+0	1.000000e+0	1.585102e+0	6.308744e-1	1	6.308744e-1	1.000000e+0	1	1.895088e-1	1.000000e+0	1.000000e+0	2.297046e+0	8.706834e-1	2	7854	1.000000e+0	2.546473e-4	unnamed	C2orf83,SLC19A3
GO Cellular Component	GO:0044464	cell part	7	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	7	9.677154e-1	1.000000e+0	1.000000e+0	6.095344e-1	1.640596e+0	1	14799	5.000000e-1	6.757213e-5	unnamed	SLC19A3
GO Cellular Component	GO:0005623	cell	8	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	8	9.677354e-1	1.000000e+0	1.000000e+0	6.094932e-1	1.640707e+0	1	14800	5.000000e-1	6.756757e-5	unnamed	SLC19A3
Mouse Phenotype	MP:0009860	nephrosclerosis	1	5.965053e-5	4.723129e-1	4.723129e-1	1.676431e+4	5.965053e-5	1	5.965053e-5	1.000000e+0	1	1.108586e-4	8.777784e-1	8.777784e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC19A3
Mouse Phenotype	MP:0011226	abnormal thiamin level	1	5.965053e-5	4.723129e-1	4.723129e-1	1.676431e+4	5.965053e-5	1	5.965053e-5	1.000000e+0	1	1.108586e-4	8.777784e-1	8.777784e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC19A3
Mouse Phenotype	MP:0001671	abnormal vitamin absorption	3	1.650267e-4	1.000000e+0	4.355605e-1	6.059626e+3	1.650267e-4	1	1.650267e-4	1.000000e+0	3	5.542315e-4	1.000000e+0	1.000000e+0	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	SLC19A3
Mouse Phenotype	MP:0005400	abnormal vitamin level	4	3.885776e-3	1.000000e+0	1.000000e+0	2.573488e+2	3.885776e-3	1	3.885776e-3	1.000000e+0	4	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	SLC19A3
Mouse Phenotype	MP:0004019	abnormal vitamin homeostasis	5	4.888990e-3	1.000000e+0	1.000000e+0	2.045412e+2	4.888990e-3	1	4.888990e-3	1.000000e+0	5	6.640639e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	SLC19A3
Mouse Phenotype	MP:0001666	abnormal intestinal absorption	6	4.918701e-3	1.000000e+0	1.000000e+0	2.033057e+2	4.918701e-3	1	4.918701e-3	1.000000e+0	6	6.861613e-3	1.000000e+0	1.000000e+0	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	SLC19A3
Mouse Phenotype	MP:0001654	hepatic necrosis	7	9.855806e-3	1.000000e+0	1.000000e+0	1.014630e+2	9.855806e-3	1	9.855806e-3	1.000000e+0	8	1.028356e-2	1.000000e+0	1.000000e+0	9.699462e+1	1.030985e-2	1	93	5.000000e-1	1.075269e-2	unnamed	SLC19A3
Mouse Phenotype	MP:0001664	abnormal digestion	8	9.947977e-3	1.000000e+0	1.000000e+0	1.005230e+2	9.947977e-3	1	9.947977e-3	1.000000e+0	9	1.248814e-2	1.000000e+0	1.000000e+0	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	SLC19A3
Mouse Phenotype	MP:0004756	abnormal proximal convoluted tubule morphology	9	1.142902e-2	1.000000e+0	1.000000e+0	8.749656e+1	1.142902e-2	1	1.142902e-2	1.000000e+0	7	1.006297e-2	1.000000e+0	1.000000e+0	9.912637e+1	1.008813e-2	1	91	5.000000e-1	1.098901e-2	unnamed	SLC19A3
Mouse Phenotype	MP:0005202	lethargy	10	1.193684e-2	1.000000e+0	1.000000e+0	8.377427e+1	1.193684e-2	1	1.193684e-2	1.000000e+0	10	1.292876e-2	1.000000e+0	1.000000e+0	7.709829e+1	1.297046e-2	1	117	5.000000e-1	8.547009e-3	unnamed	SLC19A3
Mouse Phenotype	MP:0001860	liver inflammation	11	1.214409e-2	1.000000e+0	1.000000e+0	8.234459e+1	1.214409e-2	1	1.214409e-2	1.000000e+0	11	1.513038e-2	1.000000e+0	1.000000e+0	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	SLC19A3
Mouse Phenotype	MP:0005150	cachexia	12	1.427677e-2	1.000000e+0	1.000000e+0	7.004383e+1	1.427677e-2	1	1.427677e-2	1.000000e+0	12	1.535041e-2	1.000000e+0	1.000000e+0	6.489568e+1	1.540935e-2	1	139	5.000000e-1	7.194245e-3	unnamed	SLC19A3
Mouse Phenotype	MP:0008986	abnormal liver parenchyma morphology	13	1.779930e-2	1.000000e+0	1.000000e+0	5.618197e+1	1.779930e-2	1	1.779930e-2	1.000000e+0	15	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	SLC19A3
Mouse Phenotype	MP:0001859	kidney inflammation	14	1.873100e-2	1.000000e+0	1.000000e+0	5.338744e+1	1.873100e-2	1	1.873100e-2	1.000000e+0	13	1.996530e-2	1.000000e+0	1.000000e+0	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	SLC19A3
Mouse Phenotype	MP:0011762	renal/urinary system inflammation	15	1.971468e-2	1.000000e+0	1.000000e+0	5.072363e+1	1.971468e-2	1	1.971468e-2	1.000000e+0	14	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	SLC19A3
Mouse Phenotype	MP:0002703	abnormal renal tubule morphology	16	3.058536e-2	1.000000e+0	1.000000e+0	3.269538e+1	3.058536e-2	1	3.058536e-2	1.000000e+0	16	2.752338e-2	1.000000e+0	1.000000e+0	3.608200e+1	2.771465e-2	1	250	5.000000e-1	4.000000e-3	unnamed	SLC19A3
Mouse Phenotype	MP:0000609	abnormal liver physiology	17	3.457932e-2	1.000000e+0	1.000000e+0	2.891902e+1	3.457932e-2	1	3.457932e-2	1.000000e+0	17	3.929468e-2	1.000000e+0	1.000000e+0	2.519693e+1	3.968738e-2	1	358	5.000000e-1	2.793296e-3	unnamed	SLC19A3
Mouse Phenotype	MP:0002139	abnormal hepatobiliary system physiology	18	3.845043e-2	1.000000e+0	1.000000e+0	2.600751e+1	3.845043e-2	1	3.845043e-2	1.000000e+0	19	4.266025e-2	1.000000e+0	1.000000e+0	2.318895e+1	4.312400e-2	1	389	5.000000e-1	2.570694e-3	unnamed	SLC19A3
Mouse Phenotype	MP:0001263	weight loss	19	4.066906e-2	1.000000e+0	1.000000e+0	2.458872e+1	4.066906e-2	1	4.066906e-2	1.000000e+0	18	4.168376e-2	1.000000e+0	1.000000e+0	2.373816e+1	4.212627e-2	1	380	5.000000e-1	2.631579e-3	unnamed	SLC19A3
Mouse Phenotype	MP:0002136	abnormal kidney physiology	20	4.551147e-2	1.000000e+0	1.000000e+0	2.197248e+1	4.551147e-2	1	4.551147e-2	1.000000e+0	20	4.439500e-2	1.000000e+0	1.000000e+0	2.227284e+1	4.489773e-2	1	405	5.000000e-1	2.469136e-3	unnamed	SLC19A3
Mouse Phenotype	MP:0003881	abnormal nephron morphology	21	5.265823e-2	1.000000e+0	1.000000e+0	1.899038e+1	5.265823e-2	1	5.265823e-2	1.000000e+0	21	4.872500e-2	1.000000e+0	1.000000e+0	2.027079e+1	4.933208e-2	1	445	5.000000e-1	2.247191e-3	unnamed	SLC19A3
Mouse Phenotype	MP:0001663	abnormal digestive system physiology	22	5.827484e-2	1.000000e+0	1.000000e+0	1.716006e+1	5.827484e-2	1	5.827484e-2	1.000000e+0	22	6.240758e-2	1.000000e+0	1.000000e+0	1.577010e+1	6.341112e-2	1	572	5.000000e-1	1.748252e-3	unnamed	SLC19A3
Mouse Phenotype	MP:0005502	abnormal renal/urinary system physiology	23	6.955113e-2	1.000000e+0	1.000000e+0	1.437791e+1	6.955113e-2	1	6.955113e-2	1.000000e+0	23	7.001370e-2	1.000000e+0	1.000000e+0	1.402877e+1	7.128208e-2	1	643	5.000000e-1	1.555210e-3	unnamed	SLC19A3
Mouse Phenotype	MP:0002135	abnormal kidney morphology	24	8.823365e-2	1.000000e+0	1.000000e+0	1.133354e+1	8.823365e-2	1	8.823365e-2	1.000000e+0	24	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	SLC19A3
Mouse Phenotype	MP:0001846	increased inflammatory response	25	8.879507e-2	1.000000e+0	1.000000e+0	1.126189e+1	8.879507e-2	1	8.879507e-2	1.000000e+0	29	9.886599e-2	1.000000e+0	1.000000e+0	9.858470e+0	1.014356e-1	1	915	5.000000e-1	1.092896e-3	unnamed	SLC19A3
Mouse Phenotype	MP:0000598	abnormal liver morphology	26	9.333181e-2	1.000000e+0	1.000000e+0	1.071446e+1	9.333181e-2	1	9.333181e-2	1.000000e+0	26	9.412402e-2	1.000000e+0	1.000000e+0	1.036839e+1	9.644698e-2	1	870	5.000000e-1	1.149425e-3	unnamed	SLC19A3
Mouse Phenotype	MP:0002138	abnormal hepatobiliary system morphology	27	9.450540e-2	1.000000e+0	1.000000e+0	1.058141e+1	9.450540e-2	1	9.450540e-2	1.000000e+0	27	9.549520e-2	1.000000e+0	1.000000e+0	1.021574e+1	9.788814e-2	1	883	5.000000e-1	1.132503e-3	unnamed	SLC19A3
Mouse Phenotype	MP:0000516	abnormal renal/urinary system morphology	28	9.778842e-2	1.000000e+0	1.000000e+0	1.022616e+1	9.778842e-2	1	9.778842e-2	1.000000e+0	25	8.407233e-2	1.000000e+0	1.000000e+0	1.163935e+1	8.591541e-2	1	775	5.000000e-1	1.290323e-3	unnamed	SLC19A3
Mouse Phenotype	MP:0001845	abnormal inflammatory response	29	1.012612e-1	1.000000e+0	1.000000e+0	9.875447e+0	1.012612e-1	1	1.012612e-1	1.000000e+0	32	1.166678e-1	1.000000e+0	1.000000e+0	8.313825e+0	1.202816e-1	1	1085	5.000000e-1	9.216590e-4	unnamed	SLC19A3
Mouse Phenotype	MP:0005370	liver/biliary system phenotype	30	1.044353e-1	1.000000e+0	1.000000e+0	9.575307e+0	1.044353e-1	1	1.044353e-1	1.000000e+0	30	1.082079e-1	1.000000e+0	1.000000e+0	8.984562e+0	1.113020e-1	1	1004	5.000000e-1	9.960159e-4	unnamed	SLC19A3
Mouse Phenotype	MP:0003313	abnormal locomotor activation	31	1.143198e-1	1.000000e+0	1.000000e+0	8.747388e+0	1.143198e-1	1	1.143198e-1	1.000000e+0	28	9.675999e-2	1.000000e+0	1.000000e+0	1.007877e+1	9.921845e-2	1	895	5.000000e-1	1.117318e-3	unnamed	SLC19A3
Mouse Phenotype	MP:0005367	renal/urinary system phenotype	32	1.190804e-1	1.000000e+0	1.000000e+0	8.397691e+0	1.190804e-1	1	1.190804e-1	1.000000e+0	31	1.092545e-1	1.000000e+0	1.000000e+0	8.895957e+0	1.124106e-1	1	1014	5.000000e-1	9.861933e-4	unnamed	SLC19A3
Mouse Phenotype	MP:0005381	digestive/alimentary phenotype	33	1.385091e-1	1.000000e+0	1.000000e+0	7.219740e+0	1.385091e-1	1	1.385091e-1	1.000000e+0	33	1.223892e-1	1.000000e+0	1.000000e+0	7.912719e+0	1.263788e-1	1	1140	5.000000e-1	8.771930e-4	unnamed	SLC19A3
Mouse Phenotype	MP:0002083	premature death	34	1.449089e-1	1.000000e+0	1.000000e+0	6.900889e+0	1.449089e-1	1	1.449089e-1	1.000000e+0	35	1.369718e-1	1.000000e+0	1.000000e+0	7.041764e+0	1.420099e-1	1	1281	5.000000e-1	7.806401e-4	unnamed	SLC19A3
Mouse Phenotype	MP:0001392	abnormal locomotor behavior	35	1.510711e-1	1.000000e+0	1.000000e+0	6.619401e+0	1.510711e-1	1	1.510711e-1	1.000000e+0	34	1.309881e-1	1.000000e+0	1.000000e+0	7.375715e+0	1.355801e-1	1	1223	5.000000e-1	8.176615e-4	unnamed	SLC19A3
Mouse Phenotype	MP:0003491	abnormal voluntary movement	36	1.639822e-1	1.000000e+0	1.000000e+0	6.098224e+0	1.639822e-1	1	1.639822e-1	1.000000e+0	36	1.399559e-1	1.000000e+0	1.000000e+0	6.885878e+0	1.452248e-1	1	1310	5.000000e-1	7.633588e-4	unnamed	SLC19A3
Mouse Phenotype	MP:0001262	decreased body weight	37	1.844836e-1	1.000000e+0	1.000000e+0	5.420536e+0	1.844836e-1	1	1.844836e-1	1.000000e+0	37	1.675922e-1	1.000000e+0	1.000000e+0	5.705566e+0	1.752674e-1	1	1581	5.000000e-1	6.325111e-4	unnamed	SLC19A3
Mouse Phenotype	MP:0001790	abnormal immune system physiology	38	1.911135e-1	1.000000e+0	1.000000e+0	5.232494e+0	1.911135e-1	1	1.911135e-1	1.000000e+0	41	2.153363e-1	1.000000e+0	1.000000e+0	4.378883e+0	2.283687e-1	1	2060	5.000000e-1	4.854369e-4	unnamed	SLC19A3
Mouse Phenotype	MP:0001259	abnormal body weight	39	2.081556e-1	1.000000e+0	1.000000e+0	4.804098e+0	2.081556e-1	1	2.081556e-1	1.000000e+0	39	1.952745e-1	1.000000e+0	1.000000e+0	4.857566e+0	2.058644e-1	1	1857	5.000000e-1	5.385030e-4	unnamed	SLC19A3
Mouse Phenotype	MP:0002066	abnormal motor capabilities/coordination/movement	40	2.177788e-1	1.000000e+0	1.000000e+0	4.591816e+0	2.177788e-1	1	2.177788e-1	1.000000e+0	38	1.858990e-1	1.000000e+0	1.000000e+0	5.116563e+0	1.954437e-1	1	1763	5.000000e-1	5.672150e-4	unnamed	SLC19A3
Mouse Phenotype	MP:0001265	decreased body size	41	2.412513e-1	1.000000e+0	1.000000e+0	4.145055e+0	2.412513e-1	1	2.412513e-1	1.000000e+0	40	2.125842e-1	1.000000e+0	1.000000e+0	4.439222e+0	2.252647e-1	1	2032	5.000000e-1	4.921260e-4	unnamed	SLC19A3
Mouse Phenotype	MP:0005387	immune system phenotype	42	2.446842e-1	1.000000e+0	1.000000e+0	4.086901e+0	2.446842e-1	1	2.446842e-1	1.000000e+0	45	2.754183e-1	1.000000e+0	1.000000e+0	3.360842e+0	2.975445e-1	1	2684	5.000000e-1	3.725782e-4	unnamed	SLC19A3
Mouse Phenotype	MP:0003956	abnormal body size	43	2.623454e-1	1.000000e+0	1.000000e+0	3.811768e+0	2.623454e-1	1	2.623454e-1	1.000000e+0	42	2.384377e-1	1.000000e+0	1.000000e+0	3.927079e+0	2.546422e-1	1	2297	5.000000e-1	4.353505e-4	unnamed	SLC19A3
Mouse Phenotype	MP:0002089	abnormal postnatal growth/weight/body size	44	2.800528e-1	1.000000e+0	1.000000e+0	3.570755e+0	2.800528e-1	1	2.800528e-1	1.000000e+0	44	2.591915e-1	1.000000e+0	1.000000e+0	3.589534e+0	2.785877e-1	1	2513	5.000000e-1	3.979308e-4	unnamed	SLC19A3
Mouse Phenotype	MP:0004924	abnormal behavior	45	2.945352e-1	1.000000e+0	1.000000e+0	3.395180e+0	2.945352e-1	1	2.945352e-1	1.000000e+0	43	2.543172e-1	1.000000e+0	1.000000e+0	3.663891e+0	2.729339e-1	1	2462	5.000000e-1	4.061738e-4	unnamed	SLC19A3
Mouse Phenotype	MP:0001764	abnormal homeostasis	46	2.990593e-1	1.000000e+0	1.000000e+0	3.343818e+0	2.990593e-1	1	2.990593e-1	1.000000e+0	46	3.044696e-1	1.000000e+0	1.000000e+0	3.011853e+0	3.320215e-1	1	2995	5.000000e-1	3.338898e-4	unnamed	SLC19A3
Mouse Phenotype	MP:0005376	homeostasis/metabolism phenotype	47	3.389663e-1	1.000000e+0	1.000000e+0	2.950146e+0	3.389663e-1	1	3.389663e-1	1.000000e+0	48	3.467977e-1	1.000000e+0	1.000000e+0	2.607081e+0	3.835708e-1	1	3460	5.000000e-1	2.890173e-4	unnamed	SLC19A3
Mouse Phenotype	MP:0005378	growth/size phenotype	48	3.447235e-1	1.000000e+0	1.000000e+0	2.900875e+0	3.447235e-1	1	3.447235e-1	1.000000e+0	47	3.172618e-1	1.000000e+0	1.000000e+0	2.878271e+0	3.474309e-1	1	3134	5.000000e-1	3.190810e-4	unnamed	SLC19A3
Mouse Phenotype	MP:0010769	abnormal survival	49	3.982821e-1	1.000000e+0	1.000000e+0	2.510783e+0	3.982821e-1	1	3.982821e-1	1.000000e+0	49	3.748920e-1	1.000000e+0	1.000000e+0	2.388271e+0	4.187129e-1	1	3777	5.000000e-1	2.647604e-4	unnamed	SLC19A3
Mouse Phenotype	MP:0010768	mortality/aging	50	4.155501e-1	1.000000e+0	1.000000e+0	2.406449e+0	4.155501e-1	1	4.155501e-1	1.000000e+0	50	3.982479e-1	1.000000e+0	1.000000e+0	2.229486e+0	4.485339e-1	1	4046	5.000000e-1	2.471577e-4	unnamed	SLC19A3
Mouse Phenotype	MP:0000001	mammalian phenotype	51	6.422596e-1	1.000000e+0	1.000000e+0	1.557003e+0	6.422596e-1	1	6.422596e-1	1.000000e+0	51	6.601828e-1	1.000000e+0	1.000000e+0	1.198897e+0	8.341001e-1	1	7524	5.000000e-1	1.329080e-4	unnamed	SLC19A3
Human Phenotype	HP:0002300	Mutism	1	3.881924e-4	1.000000e+0	1.000000e+0	2.576042e+3	3.881924e-4	1	3.881924e-4	1.000000e+0	1	9.975062e-4	1.000000e+0	1.000000e+0	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	SLC19A3
Human Phenotype	HP:0001289	Confusion	2	1.283812e-3	1.000000e+0	1.000000e+0	7.789303e+2	1.283812e-3	1	1.283812e-3	1.000000e+0	3	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	SLC19A3
Human Phenotype	HP:0002540	Inability to walk	3	1.765043e-3	1.000000e+0	1.000000e+0	5.665586e+2	1.765043e-3	1	1.765043e-3	1.000000e+0	2	1.219107e-3	1.000000e+0	1.000000e+0	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	SLC19A3
Human Phenotype	HP:0000544	External ophthalmoplegia	4	1.883125e-3	1.000000e+0	1.000000e+0	5.310322e+2	1.883125e-3	1	1.883125e-3	1.000000e+0	5	2.548193e-3	1.000000e+0	1.000000e+0	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	SLC19A3
Human Phenotype	HP:0002385	Paraparesis	5	2.290489e-3	1.000000e+0	1.000000e+0	4.365879e+2	2.290489e-3	1	2.290489e-3	1.000000e+0	4	2.216004e-3	1.000000e+0	1.000000e+0	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	SLC19A3
Human Phenotype	HP:0002063	Rigidity	6	3.045050e-3	1.000000e+0	1.000000e+0	3.284018e+2	3.045050e-3	1	3.045050e-3	1.000000e+0	7	5.424845e-3	1.000000e+0	1.000000e+0	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	SLC19A3
Human Phenotype	HP:0001945	Fever	7	3.941407e-3	1.000000e+0	1.000000e+0	2.537165e+2	3.941407e-3	1	3.941407e-3	1.000000e+0	7	5.424845e-3	1.000000e+0	1.000000e+0	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	SLC19A3
Human Phenotype	HP:0000602	Ophthalmoplegia	8	4.301437e-3	1.000000e+0	1.000000e+0	2.324805e+2	4.301437e-3	1	4.301437e-3	1.000000e+0	10	5.867038e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	SLC19A3
Human Phenotype	HP:0010551	Paraplegia/paraparesis	9	4.576718e-3	1.000000e+0	1.000000e+0	2.184972e+2	4.576718e-3	1	4.576718e-3	1.000000e+0	9	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	SLC19A3
Human Phenotype	HP:0001259	Coma	10	5.560377e-3	1.000000e+0	1.000000e+0	1.798439e+2	5.560377e-3	1	5.560377e-3	1.000000e+0	11	6.530143e-3	1.000000e+0	1.000000e+0	1.528898e+2	6.540657e-3	1	59	5.000000e-1	1.694915e-2	unnamed	SLC19A3
Human Phenotype	HP:0002066	Gait ataxia	11	5.647633e-3	1.000000e+0	1.000000e+0	1.770653e+2	5.647633e-3	1	5.647633e-3	1.000000e+0	6	5.093135e-3	1.000000e+0	1.000000e+0	1.960978e+2	5.099496e-3	1	46	5.000000e-1	2.173913e-2	unnamed	SLC19A3
Human Phenotype	HP:0003621	Juvenile onset	12	6.155215e-3	1.000000e+0	1.000000e+0	1.624639e+2	6.155215e-3	1	6.155215e-3	1.000000e+0	13	9.621709e-3	1.000000e+0	1.000000e+0	1.036839e+2	9.644698e-3	1	87	5.000000e-1	1.149425e-2	unnamed	SLC19A3
Human Phenotype	HP:0001298	Encephalopathy	13	6.546159e-3	1.000000e+0	1.000000e+0	1.527613e+2	6.546159e-3	1	6.546159e-3	1.000000e+0	12	7.634827e-3	1.000000e+0	1.000000e+0	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	SLC19A3
Human Phenotype	HP:0002015	Dysphagia	14	1.052458e-2	1.000000e+0	1.000000e+0	9.501563e+1	1.052458e-2	1	1.052458e-2	1.000000e+0	14	1.193722e-2	1.000000e+0	1.000000e+0	8.352315e+1	1.197273e-2	1	108	5.000000e-1	9.259259e-3	unnamed	SLC19A3
Human Phenotype	HP:0001332	Dystonia	15	1.072440e-2	1.000000e+0	1.000000e+0	9.324529e+1	1.072440e-2	1	1.072440e-2	1.000000e+0	15	1.391979e-2	1.000000e+0	1.000000e+0	7.159127e+1	1.396818e-2	1	126	5.000000e-1	7.936508e-3	unnamed	SLC19A3
Human Phenotype	HP:0004370	Abnormality of temperature regulation	16	1.075062e-2	1.000000e+0	1.000000e+0	9.301791e+1	1.075062e-2	1	1.075062e-2	1.000000e+0	16	1.469025e-2	1.000000e+0	1.000000e+0	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	SLC19A3
Human Phenotype	HP:0000597	Ophthalmoparesis	17	1.196580e-2	1.000000e+0	1.000000e+0	8.357152e+1	1.196580e-2	1	1.196580e-2	1.000000e+0	18	1.667005e-2	1.000000e+0	1.000000e+0	5.973841e+1	1.673965e-2	1	151	5.000000e-1	6.622517e-3	unnamed	SLC19A3
Human Phenotype	HP:0004372	Reduced consciousness/confusion	18	1.224302e-2	1.000000e+0	1.000000e+0	8.167919e+1	1.224302e-2	1	1.224302e-2	1.000000e+0	17	1.524040e-2	1.000000e+0	1.000000e+0	6.536594e+1	1.529849e-2	1	138	5.000000e-1	7.246377e-3	unnamed	SLC19A3
Human Phenotype	HP:0001260	Dysarthria	19	1.657413e-2	1.000000e+0	1.000000e+0	6.033498e+1	1.657413e-2	1	1.657413e-2	1.000000e+0	19	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	SLC19A3
Human Phenotype	HP:0010549	Paralysis due to lesions of the principle motor tracts	20	2.184856e-2	1.000000e+0	1.000000e+0	4.576962e+1	2.184856e-2	1	2.184856e-2	1.000000e+0	20	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	SLC19A3
Human Phenotype	HP:0001251	Ataxia	21	2.648195e-2	1.000000e+0	1.000000e+0	3.776157e+1	2.648195e-2	1	2.648195e-2	1.000000e+0	24	3.210963e-2	1.000000e+0	1.000000e+0	3.089212e+1	3.237071e-2	1	292	5.000000e-1	3.424658e-3	unnamed	SLC19A3
Human Phenotype	HP:0002031	Abnormality of the esophagus	22	2.788607e-2	1.000000e+0	1.000000e+0	3.586019e+1	2.788607e-2	1	2.788607e-2	1.000000e+0	21	2.478833e-2	1.000000e+0	1.000000e+0	4.009111e+1	2.494318e-2	1	225	5.000000e-1	4.444444e-3	unnamed	SLC19A3
Human Phenotype	HP:0100851	Abnormal emotion/affect behavior	23	2.918196e-2	1.000000e+0	1.000000e+0	3.426774e+1	2.918196e-2	1	2.918196e-2	1.000000e+0	22	2.785133e-2	1.000000e+0	1.000000e+0	3.565415e+1	2.804723e-2	1	253	5.000000e-1	3.952569e-3	unnamed	SLC19A3
Human Phenotype	HP:0000508	Ptosis	24	2.965278e-2	1.000000e+0	1.000000e+0	3.372365e+1	2.965278e-2	1	2.965278e-2	1.000000e+0	23	3.112777e-2	1.000000e+0	1.000000e+0	3.187456e+1	3.137298e-2	1	283	5.000000e-1	3.533569e-3	unnamed	SLC19A3
Human Phenotype	HP:0001288	Gait disturbance	25	3.682158e-2	1.000000e+0	1.000000e+0	2.715798e+1	3.682158e-2	1	3.682158e-2	1.000000e+0	25	3.603207e-2	1.000000e+0	1.000000e+0	2.750152e+1	3.636162e-2	1	328	5.000000e-1	3.048780e-3	unnamed	SLC19A3
Human Phenotype	HP:0011443	Abnormality of coordination	26	4.159660e-2	1.000000e+0	1.000000e+0	2.404043e+1	4.159660e-2	1	4.159660e-2	1.000000e+0	27	4.482844e-2	1.000000e+0	1.000000e+0	2.205501e+1	4.534117e-2	1	409	5.000000e-1	2.444988e-3	unnamed	SLC19A3
Human Phenotype	HP:0002167	Neurological speech impairment	27	4.456011e-2	1.000000e+0	1.000000e+0	2.244160e+1	4.456011e-2	1	4.456011e-2	1.000000e+0	26	4.276871e-2	1.000000e+0	1.000000e+0	2.312949e+1	4.323485e-2	1	390	5.000000e-1	2.564103e-3	unnamed	SLC19A3
Human Phenotype	HP:0001317	Abnormality of the cerebellum	28	4.894940e-2	1.000000e+0	1.000000e+0	2.042926e+1	4.894940e-2	1	4.894940e-2	1.000000e+0	29	5.423149e-2	1.000000e+0	1.000000e+0	1.818649e+1	5.498587e-2	1	496	5.000000e-1	2.016129e-3	unnamed	SLC19A3
Human Phenotype	HP:0000639	Nystagmus	29	5.150322e-2	1.000000e+0	1.000000e+0	1.941626e+1	5.150322e-2	1	5.150322e-2	1.000000e+0	28	5.293728e-2	1.000000e+0	1.000000e+0	1.863740e+1	5.365556e-2	1	484	5.000000e-1	2.066116e-3	unnamed	SLC19A3
Human Phenotype	HP:0011007	Age of onset	30	5.358267e-2	1.000000e+0	1.000000e+0	1.866275e+1	5.358267e-2	1	5.358267e-2	1.000000e+0	32	6.380257e-2	1.000000e+0	1.000000e+0	1.541966e+1	6.485228e-2	1	585	5.000000e-1	1.709402e-3	unnamed	SLC19A3
Human Phenotype	HP:0003674	Onset	31	5.502040e-2	1.000000e+0	1.000000e+0	1.817508e+1	5.502040e-2	1	5.502040e-2	1.000000e+0	35	6.530370e-2	1.000000e+0	1.000000e+0	1.505927e+1	6.640430e-2	1	599	5.000000e-1	1.669449e-3	unnamed	SLC19A3
Human Phenotype	HP:0000496	Abnormality of eye movement	32	5.789715e-2	1.000000e+0	1.000000e+0	1.727201e+1	5.789715e-2	1	5.789715e-2	1.000000e+0	30	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	SLC19A3
Human Phenotype	HP:0007256	Abnormality of pyramidal motor function	33	5.852599e-2	1.000000e+0	1.000000e+0	1.708643e+1	5.852599e-2	1	5.852599e-2	1.000000e+0	33	6.466050e-2	1.000000e+0	1.000000e+0	1.521164e+1	6.573915e-2	1	593	5.000000e-1	1.686341e-3	unnamed	SLC19A3
Human Phenotype	HP:0002062	Abnormality of the pyramidal tracts	34	5.873395e-2	1.000000e+0	1.000000e+0	1.702593e+1	5.873395e-2	1	5.873395e-2	1.000000e+0	34	6.498213e-2	1.000000e+0	1.000000e+0	1.513507e+1	6.607173e-2	1	596	5.000000e-1	1.677852e-3	unnamed	SLC19A3
Human Phenotype	HP:0000708	Behavioural/Psychiatric Abnormality	35	6.042589e-2	1.000000e+0	1.000000e+0	1.654920e+1	6.042589e-2	1	6.042589e-2	1.000000e+0	30	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	SLC19A3
Human Phenotype	HP:0011024	Abnormality of the gastrointestinal tract	36	6.745114e-2	1.000000e+0	1.000000e+0	1.482555e+1	6.745114e-2	1	6.745114e-2	1.000000e+0	36	6.626808e-2	1.000000e+0	1.000000e+0	1.483635e+1	6.740203e-2	1	608	5.000000e-1	1.644737e-3	unnamed	SLC19A3
Human Phenotype	HP:0100022	Abnormality of movement	37	7.002976e-2	1.000000e+0	1.000000e+0	1.427964e+1	7.002976e-2	1	7.002976e-2	1.000000e+0	37	7.172348e-2	1.000000e+0	1.000000e+0	1.368816e+1	7.305582e-2	1	659	5.000000e-1	1.517451e-3	unnamed	SLC19A3
Human Phenotype	HP:0001250	Seizures	38	7.857598e-2	1.000000e+0	1.000000e+0	1.272654e+1	7.857598e-2	1	7.857598e-2	1.000000e+0	38	8.216155e-2	1.000000e+0	1.000000e+0	1.191612e+1	8.391996e-2	1	757	5.000000e-1	1.321004e-3	unnamed	SLC19A3
Human Phenotype	HP:0011442	Abnormality of central motor function	39	7.946206e-2	1.000000e+0	1.000000e+0	1.258462e+1	7.946206e-2	1	7.946206e-2	1.000000e+0	39	8.767615e-2	1.000000e+0	1.000000e+0	1.115019e+1	8.968461e-2	1	809	5.000000e-1	1.236094e-3	unnamed	SLC19A3
Human Phenotype	HP:0000004	Onset and clinical course	40	8.609761e-2	1.000000e+0	1.000000e+0	1.161472e+1	8.609761e-2	1	8.609761e-2	1.000000e+0	41	9.886599e-2	1.000000e+0	1.000000e+0	9.858470e+0	1.014356e-1	1	915	5.000000e-1	1.092896e-3	unnamed	SLC19A3
Human Phenotype	HP:0012443	Abnormality of the brain	41	9.259756e-2	1.000000e+0	1.000000e+0	1.079942e+1	9.259756e-2	1	9.259756e-2	1.000000e+0	40	9.833972e-2	1.000000e+0	1.000000e+0	9.912637e+0	1.008813e-1	1	910	5.000000e-1	1.098901e-3	unnamed	SLC19A3
Human Phenotype	HP:0002012	Abnormality of the abdominal organs	42	9.395144e-2	1.000000e+0	1.000000e+0	1.064380e+1	9.395144e-2	1	9.395144e-2	1.000000e+0	42	1.060080e-1	1.000000e+0	1.000000e+0	9.176501e+0	1.089740e-1	1	983	5.000000e-1	1.017294e-3	unnamed	SLC19A3
Human Phenotype	HP:0012373	Abnormal eye physiology	43	1.069560e-1	1.000000e+0	1.000000e+0	9.349641e+0	1.069560e-1	1	1.069560e-1	1.000000e+0	43	1.137480e-1	1.000000e+0	1.000000e+0	8.534059e+0	1.171775e-1	1	1057	5.000000e-1	9.460738e-4	unnamed	SLC19A3
Human Phenotype	HP:0001939	Abnormality of metabolism/homeostasis	44	1.159749e-1	1.000000e+0	1.000000e+0	8.622554e+0	1.159749e-1	1	1.159749e-1	1.000000e+0	46	1.414974e-1	1.000000e+0	1.000000e+0	6.807925e+0	1.468876e-1	1	1325	5.000000e-1	7.547170e-4	unnamed	SLC19A3
Human Phenotype	HP:0001438	Abnormality of the abdomen	45	1.198484e-1	1.000000e+0	1.000000e+0	8.343876e+0	1.198484e-1	1	1.198484e-1	1.000000e+0	44	1.315047e-1	1.000000e+0	1.000000e+0	7.345684e+0	1.361344e-1	1	1228	5.000000e-1	8.143322e-4	unnamed	SLC19A3
Human Phenotype	HP:0007319	Morphological abnormality of the central nervous system	46	1.231213e-1	1.000000e+0	1.000000e+0	8.122074e+0	1.231213e-1	1	1.231213e-1	1.000000e+0	45	1.321245e-1	1.000000e+0	1.000000e+0	7.309968e+0	1.367995e-1	1	1234	5.000000e-1	8.103728e-4	unnamed	SLC19A3
Human Phenotype	HP:0000007	Autosomal recessive inheritance	47	1.382544e-1	1.000000e+0	1.000000e+0	7.233043e+0	1.382544e-1	1	1.382544e-1	1.000000e+0	49	1.705229e-1	1.000000e+0	1.000000e+0	5.602795e+0	1.784823e-1	1	1610	5.000000e-1	6.211180e-4	unnamed	SLC19A3
Human Phenotype	HP:0000478	Abnormality of the eye	48	1.387497e-1	1.000000e+0	1.000000e+0	7.207222e+0	1.387497e-1	1	1.387497e-1	1.000000e+0	47	1.483658e-1	1.000000e+0	1.000000e+0	6.480244e+0	1.543152e-1	1	1392	5.000000e-1	7.183908e-4	unnamed	SLC19A3
Human Phenotype	HP:0011446	Abnormality of higher mental function	49	1.446140e-1	1.000000e+0	1.000000e+0	6.914961e+0	1.446140e-1	1	1.446140e-1	1.000000e+0	48	1.507173e-1	1.000000e+0	1.000000e+0	6.374912e+0	1.568649e-1	1	1415	5.000000e-1	7.067138e-4	unnamed	SLC19A3
Human Phenotype	HP:0002011	Abnormality of the central nervous system	50	1.748665e-1	1.000000e+0	1.000000e+0	5.718647e+0	1.748665e-1	1	1.748665e-1	1.000000e+0	50	1.821938e-1	1.000000e+0	1.000000e+0	5.226246e+0	1.913419e-1	1	1726	5.000000e-1	5.793743e-4	unnamed	SLC19A3
Human Phenotype	HP:0000707	Abnormality of the nervous system	51	1.846645e-1	1.000000e+0	1.000000e+0	5.415226e+0	1.846645e-1	1	1.846645e-1	1.000000e+0	51	1.902943e-1	1.000000e+0	1.000000e+0	4.991976e+0	2.003215e-1	1	1807	5.000000e-1	5.534034e-4	unnamed	SLC19A3
Human Phenotype	HP:0000005	Mode of inheritance	52	2.495240e-1	1.000000e+0	1.000000e+0	4.007630e+0	2.495240e-1	1	2.495240e-1	1.000000e+0	52	2.693662e-1	1.000000e+0	1.000000e+0	3.442939e+0	2.904495e-1	1	2620	5.000000e-1	3.816794e-4	unnamed	SLC19A3
Human Phenotype	HP:0000118	Phenotypic abnormality	53	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	53	2.856679e-1	1.000000e+0	1.000000e+0	3.229681e+0	3.096281e-1	1	2793	5.000000e-1	3.580380e-4	unnamed	SLC19A3
Human Phenotype	HP:0000001	All	54	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	54	2.883826e-1	1.000000e+0	1.000000e+0	3.196492e+0	3.128430e-1	1	2822	5.000000e-1	3.543586e-4	unnamed	SLC19A3
Disease Ontology	DOID:4241	malignant neoplasm of breast	1	1.689834e-1	1.000000e+0	1.000000e+0	5.917740e+0	1.689834e-1	1	1.689834e-1	1.000000e+0	1	1.624258e-1	1.000000e+0	1.000000e+0	5.895752e+0	1.696137e-1	1	1530	5.000000e-1	6.535948e-4	unnamed	SLC19A3
Disease Ontology	DOID:3937	malignant neoplasm of thorax	2	1.691008e-1	1.000000e+0	1.000000e+0	5.913634e+0	1.691008e-1	1	1.691008e-1	1.000000e+0	2	1.626287e-1	1.000000e+0	1.000000e+0	5.888055e+0	1.698354e-1	1	1532	5.000000e-1	6.527415e-4	unnamed	SLC19A3
Disease Ontology	DOID:5093	thoracic cancer	3	1.702657e-1	1.000000e+0	1.000000e+0	5.873173e+0	1.702657e-1	1	1.702657e-1	1.000000e+0	3	1.639470e-1	1.000000e+0	1.000000e+0	5.838511e+0	1.712765e-1	1	1545	5.000000e-1	6.472492e-4	unnamed	SLC19A3
Disease Ontology	DOID:1612	mammary cancer	4	1.772500e-1	1.000000e+0	1.000000e+0	5.641748e+0	1.772500e-1	1	1.772500e-1	1.000000e+0	4	1.677945e-1	1.000000e+0	1.000000e+0	5.698358e+0	1.754892e-1	1	1583	5.000000e-1	6.317119e-4	unnamed	SLC19A3
Disease Ontology	DOID:193	reproductive system cancer	5	2.095200e-1	1.000000e+0	1.000000e+0	4.772814e+0	2.095200e-1	1	2.095200e-1	1.000000e+0	5	2.033098e-1	1.000000e+0	1.000000e+0	4.654541e+0	2.148440e-1	1	1938	5.000000e-1	5.159959e-4	unnamed	SLC19A3
Disease Ontology	DOID:462	cancer by anatomical entity	6	3.485076e-1	1.000000e+0	1.000000e+0	2.869378e+0	3.485076e-1	1	3.485076e-1	1.000000e+0	6	3.467081e-1	1.000000e+0	1.000000e+0	2.607835e+0	3.834599e-1	1	3459	5.000000e-1	2.891009e-4	unnamed	SLC19A3
Disease Ontology	DOID:162	cancer	7	4.681931e-1	1.000000e+0	1.000000e+0	2.135871e+0	4.681931e-1	1	4.681931e-1	1.000000e+0	7	4.854768e-1	1.000000e+0	1.000000e+0	1.768725e+0	5.653789e-1	1	5100	5.000000e-1	1.960784e-4	unnamed	SLC19A3
Disease Ontology	DOID:4	disease	8	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	8	6.831746e-1	1.000000e+0	1.000000e+0	1.143863e+0	8.742309e-1	1	7886	5.000000e-1	1.268070e-4	unnamed	SLC19A3
MSigDB Pathway	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS	Genes involved in Metabolism of vitamins and cofactors	1	4.559091e-3	1.000000e+0	1.000000e+0	2.193420e+2	4.559091e-3	1	4.559091e-3	1.000000e+0	1	5.535402e-3	1.000000e+0	1.000000e+0	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	SLC19A3
MSigDB Perturbation	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	Genes down-regulated in liver tumor compared to the normal adjacent tissue.	1	2.113154e-2	1.000000e+0	1.000000e+0	4.732263e+1	2.113154e-2	1	2.113154e-2	1.000000e+0	1	2.905334e-2	1.000000e+0	1.000000e+0	3.416856e+1	2.926667e-2	1	264	5.000000e-1	3.787879e-3	unnamed	SLC19A3
MSigDB Perturbation	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	Genes down-regulated in normal tissue adjacent to liver tumor, compared to the normal liver samples.	2	2.469410e-2	1.000000e+0	1.000000e+0	4.049551e+1	2.469410e-2	1	2.469410e-2	1.000000e+0	2	4.005517e-2	1.000000e+0	1.000000e+0	2.471370e+1	4.046339e-2	1	365	5.000000e-1	2.739726e-3	unnamed	SLC19A3
MSigDB Perturbation	ACEVEDO_LIVER_CANCER_DN	Genes down-regulated in hepatocellular carcinoma (HCC) compared to normal liver samples.	3	4.027354e-2	1.000000e+0	1.000000e+0	2.483020e+1	4.027354e-2	1	4.027354e-2	1.000000e+0	5	5.810880e-2	1.000000e+0	1.000000e+0	1.695583e+1	5.897678e-2	1	532	5.000000e-1	1.879699e-3	unnamed	SLC19A3
MSigDB Perturbation	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP	Genes up-regulated in macrophages by P.gingivalis LPS (lipopolysaccharide).	4	4.318233e-2	1.000000e+0	1.000000e+0	2.315762e+1	4.318233e-2	1	4.318233e-2	1.000000e+0	3	4.146669e-2	1.000000e+0	1.000000e+0	2.386376e+1	4.190455e-2	1	378	5.000000e-1	2.645503e-3	unnamed	C2orf83
MSigDB Perturbation	RAO_BOUND_BY_SALL4_ISOFORM_B	Loci bound exclusively by SALL4 [GeneID=57167] isoform b in ES cells (embryonic stem).	5	6.216749e-2	1.000000e+0	1.000000e+0	1.608558e+1	6.216749e-2	1	6.216749e-2	1.000000e+0	4	5.670958e-2	1.000000e+0	1.000000e+0	1.738054e+1	5.753561e-2	1	519	5.000000e-1	1.926782e-3	unnamed	SLC19A3
MSigDB Predicted Promoter Motifs	V$CEBPB_02	Motif NKNTTGCNYAAYNN matches CEBPB: CCAAT/enhancer binding protein (C/EBP), beta	1	3.796622e-2	1.000000e+0	1.000000e+0	2.633920e+1	3.796622e-2	1	3.796622e-2	1.000000e+0	2	2.741405e-2	1.000000e+0	1.000000e+0	3.622691e+1	2.760379e-2	1	249	5.000000e-1	4.016064e-3	unnamed	SLC19A3
MSigDB Predicted Promoter Motifs	V$OCT1_05	Motif MKVATTTGCATATT matches POU2F1: POU domain, class 2, transcription factor 1	2	4.002346e-2	1.000000e+0	1.000000e+0	2.498535e+1	4.002346e-2	1	4.002346e-2	1.000000e+0	1	2.653920e-2	1.000000e+0	1.000000e+0	3.742946e+1	2.671692e-2	1	241	5.000000e-1	4.149378e-3	unnamed	SLC19A3
MSigDB Predicted Promoter Motifs	V$OCT1_B	Motif TATGCAAATN matches POU2F1: POU domain, class 2, transcription factor 1	3	4.074448e-2	1.000000e+0	1.000000e+0	2.454320e+1	4.074448e-2	1	4.074448e-2	1.000000e+0	4	3.014542e-2	1.000000e+0	1.000000e+0	3.292153e+1	3.037526e-2	1	274	5.000000e-1	3.649635e-3	unnamed	SLC19A3
MSigDB Predicted Promoter Motifs	V$OCT1_01	Motif NNNNWTATGCAAATNTNNN matches POU2F1: POU domain, class 2, transcription factor 1	4	4.579032e-2	1.000000e+0	1.000000e+0	2.183867e+1	4.579032e-2	1	4.579032e-2	1.000000e+0	3	2.883484e-2	1.000000e+0	1.000000e+0	3.442939e+1	2.904495e-2	1	262	5.000000e-1	3.816794e-3	unnamed	SLC19A3
MSigDB Predicted Promoter Motifs	WTGAAAT_UNKNOWN	Motif WTGAAAT (no known TF)	5	9.506027e-2	1.000000e+0	1.000000e+0	1.051964e+1	9.506027e-2	1	9.506027e-2	1.000000e+0	5	6.358802e-2	1.000000e+0	1.000000e+0	1.547256e+1	6.463056e-2	1	583	5.000000e-1	1.715266e-3	unnamed	C2orf83
InterPro	IPR028337	Thiamine transporter 2	1	5.965053e-5	5.620273e-1	5.620273e-1	1.676431e+4	5.965053e-5	1	5.965053e-5	1.000000e+0	2	1.108586e-4	1.000000e+0	5.222549e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC19A3
InterPro	IPR002666	Reduced folate carrier	2	2.229109e-4	1.000000e+0	1.000000e+0	4.486097e+3	2.229109e-4	1	2.229109e-4	1.000000e+0	1	3.687093e-8	3.473979e-4	3.473979e-4	4.510250e+3	4.434344e-4	2	4	1.000000e+0	5.000000e-1	unnamed	C2orf83,SLC19A3
InterPro	IPR016196	Major facilitator superfamily domain, general substrate transporter	3	1.002249e-2	1.000000e+0	1.000000e+0	9.977556e+1	1.002249e-2	1	1.002249e-2	1.000000e+0	3	1.546041e-2	1.000000e+0	1.000000e+0	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	SLC19A3
TreeFam	TF341245	C2orf83	1	8.522588e-5	6.925455e-1	6.925455e-1	1.173353e+4	8.522588e-5	1	8.522588e-5	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	C2orf83
TreeFam	TF313684	SLC19A1, SLC19A2, SLC19A3	2	1.652385e-4	1.000000e+0	6.713640e-1	6.051859e+3	1.652385e-4	1	1.652385e-4	1.000000e+0	2	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	SLC19A3
HGNC Gene Families	SLC	SLC	1	3.126915e-2	1.000000e+0	1.000000e+0	3.198041e+1	3.126915e-2	1	3.126915e-2	1.000000e+0	1	4.070677e-2	1.000000e+0	1.000000e+0	2.431402e+1	4.112854e-2	1	371	5.000000e-1	2.695418e-3	unnamed	SLC19A3
Ensembl Genes	11800	SLC19A3	1	5.965053e-5	1.000000e+0	1.000000e+0	1.676431e+4	5.965053e-5	1	5.965053e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC19A3
Ensembl Genes	11799	C2orf83	2	8.522588e-5	1.000000e+0	7.687801e-1	1.173353e+4	8.522588e-5	1	8.522588e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	C2orf83
MSigDB Oncogenic Signatures	KRAS.AMP.LUNG_UP.V1_DN	Genes down-regulated in epithelial lung cancer cell lines over-expressing KRAS [Gene ID=3845] gene.	1	1.280966e-2	1.000000e+0	1.000000e+0	7.806609e+1	1.280966e-2	1	1.280966e-2	1.000000e+0	2	1.601034e-2	1.000000e+0	1.000000e+0	6.221034e+1	1.607450e-2	1	145	5.000000e-1	6.896552e-3	unnamed	SLC19A3
MSigDB Oncogenic Signatures	KRAS.PROSTATE_UP.V1_DN	Genes down-regulated in epithelial prostate cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.	2	1.439878e-2	1.000000e+0	1.000000e+0	6.945032e+1	1.439878e-2	1	1.439878e-2	1.000000e+0	1	1.502036e-2	1.000000e+0	1.000000e+0	6.632721e+1	1.507677e-2	1	136	5.000000e-1	7.352941e-3	unnamed	SLC19A3
MSigDB Immunologic Signatures	GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_DN	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at 1 month after the diagnosis.	1	1.476434e-2	1.000000e+0	1.000000e+0	6.773077e+1	1.476434e-2	1	1.476434e-2	1.000000e+0	2	1.996530e-2	1.000000e+0	1.000000e+0	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	C2orf83
MSigDB Immunologic Signatures	GSE3982_BCELL_VS_TH1_UP	Genes up-regulated in comparison of B cells versus Th1 cells.	2	1.682300e-2	1.000000e+0	1.000000e+0	5.944244e+1	1.682300e-2	1	1.682300e-2	1.000000e+0	4	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	C2orf83
MSigDB Immunologic Signatures	GSE3982_NEUTROPHIL_VS_TH1_UP	Genes up-regulated in comparison of neutrophils versus Th1 cells.	3	1.842481e-2	1.000000e+0	1.000000e+0	5.427465e+1	1.842481e-2	1	1.842481e-2	1.000000e+0	3	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	C2orf83
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_UP	Genes up-regulated in comparison of monocytes from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	4	1.895971e-2	1.000000e+0	1.000000e+0	5.274341e+1	1.895971e-2	1	1.895971e-2	1.000000e+0	5	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	SLC19A3
MSigDB Immunologic Signatures	GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_UP	Genes up-regulated in comparison of untreated memory CD4 [GeneID=920] T cells from young donors versus those from old donors.	5	2.083962e-2	1.000000e+0	1.000000e+0	4.798552e+1	2.083962e-2	1	2.083962e-2	1.000000e+0	1	1.952626e-2	1.000000e+0	1.000000e+0	5.096328e+1	1.962197e-2	1	177	5.000000e-1	5.649718e-3	unnamed	SLC19A3
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
